Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019)
LONDON, Sept. 23, 2014 /PRNewswire/ -- Nuclear medicine market is estimated to reach US$1.69 Billion by 2015.
Radiopharmaceuticals/ Nuclear are drugs that contain radionuclide-emitting ionization radiation, used in the nuclear imaging field to diagnose and treat diseases.
Increasing incidences of cancer and cardiac ailments, Increasing awareness for radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major driving forces for this market. Furthermore, increased public awareness and use of SPECT and PET also fuels the market growth. Growth in this market will be driven by new technology and varied uses of the technology. The major constrains for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues.
The radiopharmaceutical market is broadly classified into two segments, namely diagnostic and therapeutic. The radioisotopes in diagnostic are further categorized as SPECT and PET. The major isotopes dominating the SPECT market are Technetium-99m(Tc-99m) followed by Thallium-201(Tl-01), Gallium-67( Ga-67), and Iodoine- 123( I-123).The PET radioisotopes market is dominated by Fluoride- 18( F-18) , followed by Rubidium-82(Rb-82).SPECT is majorly used in diagnosis of cardiovascular diseases and is expected to grow at a CAGR of 6.9%. Therapeutics segments are classified as beta emitters, brachytherapy isotopes, and alpha emitters. Beta emitters are dominated by Iodine-131(I-131), brachytherapy market by Cesium-131( Cs-131), Idoine-125( I-125), Palladium-103(Pd-103) and Iridium-192(Ir-192).
Based on geography market is divided into different regions as US, Europe, Asia-Pacific and Rest of world. European market is driven by its applications for thyroid cancer, hyperthyroidism, and non-Hodgkin's lymphoma. Germany is the largest consumer market for radiopharmaceuticals in the Europe.
Major players in the radiopharmaceuticals market are Covidien Plc (Ireland), GE Healthcare (U.K.), IBA Group (Belgium), Lantheus Medical Imaging, Inc. (U.S.), Nordion Inc. (Canada), and Siemens Healthcare (PETNET) (Germany).
What makes our report unique?
1) An extensive research study on radiopharmaceuticals, Classification based on major isotopes, applications, market trends, market drivers, market constraints and market challenges.
2) We provide longest possible market segmentation based on type of type of products, type of application and geography.
3) This global report gives a bird's eye-view of the market competitive landscape which includes mergers & acquisitions, collaborations., new product launches and key players in the market.
Download the full report: https://www.reportbuyer.com/product/2378089/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article